The present study extensively explored the associations between LOX family gene polymorphisms and the risk of aSAH. We demonstrated that LOX and LOXL4 polymorphisms were associated with single IA rupture, whereas LOXL1-3 polymorphisms were associated with multiple IAs rupture, suggesting that members of the LOX family genes may have roles in aSAH.
The LOX family can be classified into two groups based on the structure of their N-terminal domains: LOX and LOXL1 have a propeptide at their N-terminal, whereas LOXL2, LOXL3, and LOXL4 have four scavenger receptor cysteine-rich domains [19]. The LOX family gene subtypes (LOX, LOXL1-4) are all amine oxidases and contain a highly conserved C-terminal binding domain that forms a special lysine tyrosylquinone cofactor-moiety after binding to the copper ion cofactor [20]. These family genes are critical enzymes that regulate the crosslinking of elastin and collagen to have a regulatory role in ECM assembly [21], while the dysregulation of ECM may disrupt the function or structure of the arterial wall, and may be a risk factor in the pathogenesis of aSAH [14, 22]. Therefore, they are plausible functional candidates for exploring the associations with aSAH.
The LOX gene is located on chromosome 5q23.3-31.2. Being a copper amine oxidase, LOX initiates the covalent cross-linking of collagen and elastin by condensing the oxidized peptidyl α-aminoadipic-δ-semialdehyde with neighboring peptidyl aldehydes, thereby consolidating the collagen and elastin fibers of the ECM [15, 23]. Genetic mouse models for LOX have also demonstrated its significant contribution to the cardiovascular system [24, 25]. In the present study, significant associations between LOX (rs1800449 and rs10519694) and single IA rupture were detected. Our results are inconsistent those of a previous study by Hong et al., who conducted a case-control study with 41 ruptured and 39 unruptured IA patients in a Korean population, suggesting that LOX may not be a susceptible gene for IA rupture [18]. We found that population heterogeneity may be the reason for this discordance between these two countries, and minor allele frequency in the two sites was discrepant between these two populations [18].
The LOXL1 gene is located on chromosome 15q24.1. The homogeneity of LOX and LOXL1 has been found to be as high as 88%, so their functions are similarly expressed [26]. The pro-sequence contained by LOX and LOXL1 can directly interact with the ECM to direct these enzyme deposits on the elastic tissues [27]. The distinction from LOX was that LOXL1 specifically locates at the elastic formation site and interacts with fibuin-5. Mice deficient in LOXL1 did not deposit normal elastic fibers postpartum, thus demonstrating their specific role in elastogenesis [28]. Recent studies have indicated that LOXL1 may also have a role in type II collagen formation and suppression, and promotion of tumor tumorigenesis [29, 30]. LOXL1 deficiency has been associated with pseudoexfoliation syndrome, idiopathic pulmonary fibrosis, and aneurysms [27]. Our present study demonstrated that LOXL1 rs2165241 was associated with multiple IAs rupture, which has not previously been found in other studies. Therefore, the association between LOXL1 polymorphisms and aSAH and its mechanism needs to be further explored.
LOXL2 is located on chromosome 8p21.3 and its protein products are helpful in maintaining the integrity and stability of the vascular wall. Thus, LOXL2 may have a susceptible role in IA rupture [44, 32]. The unbiased proteomic analysis demonstrated that LOXL2 could accelerate vascular sclerosis by promoting matrix stiffness and vascular smooth muscle stiffness and contractility [31], and additional studies have identified that LOXL2 polymorphisms are associated with blood pressure [32]. Increased vascular stiffness and high blood pressure are independent risk factors for cardiovascular diseases, such as stroke and subarachnoid hemorrhage [33]. Akagawa et al. conducted an association study to systematically screen the LOX family genes in 402 IA patients and 462 controls from a Japanese population and found that LOXL2 rs1010156 was associated with FIA [16]. Using whole-exome sequencing, a significant association was also found with LOXL2 in FIA patients from a Chinese population [17]. Similarly, our present results also demonstrated that LOXL2 is associated with IA rupture but with multiple IAs, not total IA or single IA rupture. If the same gene has different roles in the process of single and multiple IA ruptures, this may due to the higher rupture risk in patients with multiple IAs than patients with a single IA [34]; however, the mechanism of LOXL2 in IA rupture is unclear, and further studies are required.
The LOXL3 gene is located on chromosome 2p13.1 and its expression level has been found to be high in the heart, spleen, lung, aorta, and coronary arteries [35]. LOXL3 showed beta-aminopropionitrile inhibition of amine oxidase activity towards elastin and collagen; the highest activity was observed for type VIII collagen, which is a network collagen mainly expressed in vascular endothelial cells and smooth muscle cells, possibly having a role in the maintenance of vessel wall integrity [36]. Mouse models have also described the oxidative effect of LOXL3 on ECM fibronectin [37]. Recently, a LOXL3 mutation was identified in a family with a father and son, with Stickler syndrome characterized by myopia and retinopathy [38]. In the present study, we found that LOXL3 was associated with multiple IAs rupture, suggesting that a variant of LOXL3 may have a role in aSAH, but the mechanism of function needs to be further studied.
The LOXL4 gene is located on chromosome 10q24.2, and contains an additional 13 amino acid insert that differs from LOXL2 and LOXL3. LOXL4 is present in multiple human tissues, including the lung, liver, heart, brain, and colon [39]. Detected to be abnormally expressed in several tumors, the potential biological function of LOXL4 has been extended to the remodeling of the vascular ECM [40]. Although our current results suggest that LOXL4 may have a role in single IA rupture, whether it leads to IA rupture by affecting the remodeling of ECM or other methodologies is unclear; therefore, future studies are needed.
Our study had several limitations. First, the sample size was relatively small, which may have contributed to false associations due to limited statistical power; therefore, it is important to use larger studies to further verify the association between the LOX family genes and aSAH. Second, we could not modify the morphological factors for multivariate analysis due to patients with two or more aneurysms in the multiple IA group; however, considering irregular aneurysms are more likely to rupture than regular aneurysms, and irregular aneurysms were more common in the ruptured group [41, 42]. Hence, we suggest the univariate analysis results of multiple IA ruptures may provide a reference for multiple IA etiological research. Third, functional studies on susceptibility genes of IA rupture were not conducted, and we did not explore further the specific mechanisms of aSAH; therefore, further research is needed to clarify the mechanism of function in the future. Despite the above limitations, our present work provides evidence of the association between LOX family gene polymorphisms and aSAH, which can be used in future studies.